文献速递头颈外科

喉癌患者候选血管生成相关生物标志物(AngLaC):一项前瞻性队列研究

Candidate Angiogenesis-Related Biomarkers in Patients with Laryngeal Carcinoma (AngLaC): A Prospective Cohort Study.
PubMed 文献 · Otolaryngol Head Neck Surg · 2023-01-29

该前瞻性对照队列研究纳入60例喉癌患者和20例年龄性别匹配的健康对照,采用酶联免疫吸附试验检测候选血管生成相关生物标志物血清水平。患者组骨桥蛋白、IGFBP-3、VEGF、sVEGFR-1和VEGFR-2水平显著升高,高骨桥蛋白和高sVEGFR-1与局部区域复发相关,高sVEGFR-1和低VEGFR-2与较差总生存相关。

要点

  • 喉癌患者血清骨桥蛋白、IGFBP-3、VEGF、sVEGFR-1和VEGFR-2水平显著高于健康对照。
  • 高骨桥蛋白和高sVEGFR-1水平与局部区域复发相关。
  • 高sVEGFR-1和低VEGFR-2水平与较差总生存相关。

核心结论

  • 高血清sVEGFR-1和骨桥蛋白水平以及低血清VEGFR-2水平在喉癌中显示为不良预后因素。
  • VEGF、sVEGFR1、VEGFR2、IGFBP-3和骨桥蛋白水平在喉癌患者中较正常人群显著升高。
  • 需要进一步研究骨桥蛋白和sVEGFR-1以确定其与复发的关联。

研究设计与样本

  • 研究为前瞻性对照队列研究,在三级转诊中心进行。
  • 研究纳入60例喉癌患者和20例健康对照,对照年龄和性别匹配。
  • 通过计算机模拟分析血管生成相关基因以确定候选生物标志物,并用酶联免疫吸附试验测定血清水平。

主要发现

  • 患者组骨桥蛋白、IGFBP-3、VEGF、sVEGFR-1和VEGFR-2血清水平显著高于对照组(p < .001、p ≤ .001、p < .001、p < .01、p < .01)。
  • 高骨桥蛋白和高sVEGFR-1水平与局部区域复发相关(p = .024、p = .016)。
  • IGFBP-3在研究的分子中具有最高诊断敏感性(81.4%)和特异性(80%)(p < .001)。
  • 高sVEGFR-1和低VEGFR-2水平与较差总生存相关(p = .037、p = .027)。
  • 高骨桥蛋白和高sVEGFR-1水平与较差疾病特异性生存率相关(p = .035、p = .018)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 需要进一步研究骨桥蛋白和sVEGFR-1以确定其与复发的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Angiogenesis is indeed a vital process in the progression of carcinomas, including that of larynx. Therefore, this study (AngLaC) aimed to identify candidate angiogenesis-related biomarkers in laryngeal carcinoma patients. STUDY DESIGN: Prospective controlled cohort study. SETTING: Tertiary referral center. METHODS: In silico analyses of angiogenesis-related genes in laryngeal carcinoma were performed to determine candidate biomarkers. Serum levels of candidate biomarkers were determined via enzyme-linked immunosorbent assay in laryngeal carcinoma patients as well as in an age and gender-matched control group. The associations of the biomarkers with clinical parameters were investigated. RESULTS: The study included 60 laryngeal carcinoma patients and 20 healthy controls. The serum levels of osteopontin, IGFBP-3, VEGF, sVEGFR-1, and VEGFR-2 were significantly higher in the patient group (p < .001, p ≤ .001, p < .001, p < .01, p < .01, respectively). High osteopontin and sVEGFR-1 levels were associated with locoregional-recurrence (p = .024, p = .016, respectively). IGFBP-3 had the highest diagnostic sensitivity (81.4%) and specificity (80%) among the molecules that were investigated (p < .001). High sVEGFR-1 and low VEGFR-2 levels were associated with poor overall-survival (p = .037, p = .027, respectively). High osteopontin and sVEGFR-1 levels were associated with poor disease-specific survival rates (p = .035, p = .018, respectively). CONCLUSION: High serum levels of sVEGFR-1 and osteopontin as well as low serum levels of VEGFR-2 proved to be poor prognostic in terms of survival in laryngeal carcinoma. VEGF, sVEGFR1, VEGFR2, IGFBP-3, and osteopontin levels were found to be significantly increased in larynx cancer patients compared to the normal population. Further studies on osteopontin and sVEGFR-1 are required in order to determine their associations with recurrence.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Pamuk AE, Gedik ME, Sutay Suslu N, et al. Candidate Angiogenesis-Related Biomarkers in Patients with Laryngeal Carcinoma (AngLaC): A Prospective Cohort Study. Otolaryngol Head Neck Surg. 2023. PMID: 36939422. doi:10.1002/ohn.219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。